GTS Securities’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-105,000
Closed -$7.04M – 2048
2024
Q3
$7.04M Buy
105,000
+69,500
+196% +$5.71M 0.02% 679
2024
Q2
$4.02M Sell
35,500
-27,100
-43% -$3.43M 0.01% 1006
2024
Q1
$8.68M Sell
62,600
-500
-0.8% -$62.8K 0.02% 570
2023
Q4
$7.83M Sell
63,100
-8,000
-11% -$817K 0.01% 734
2023
Q3
$6.63M Buy
+71,100
New +$8.01M 0.01% 786

Other funds holding DXCM

GTS Securities's DXCM Position: Q3 2026 in Review

GTS Securities opened a new position in DexCom (DXCM) in Q3 2026: 8,520 shares worth $735K. The stake represents 0.02% of the portfolio and ranks #664 among its holdings. This is a return to the name: GTS Securities previously reported a position in DXCM as recently as Q1 2026.

GTS Securities first reported a position in DXCM in Q2 2023 and has held it in 11 quarters since. The position peaked at $2.63M in Q3 2024. 1,056 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • GTS Securities held 8,520 shares of DexCom worth $735K as of Q3 2026.
  • DexCom was a new GTS Securities position in Q3 2026.
  • DexCom made up 0.02% of GTS Securities's portfolio in Q3 2026, its #664 holding.
  • GTS Securities first reported a position in DexCom in Q2 2023 and has held it in 11 quarters since.
  • GTS Securities's DexCom position peaked at $2.63M in Q3 2024.
  • 1,056 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.